In the past few days there’s been media coverage of the start of New Zealand trials of a new non-invasive bowel cancer detection system. It’s a SIFT-MS unit that undertakes the analysis and we thought you might be interested to read a media release we’ve issued – click here. The earlier media coverage didn’t specifically name Syft. The New Zealand trials will be a collaboration between Syft, Imperial College London, the University of Otago’s Wellington School of Medicine and Callaghan Innovation.
Image: George Hanna performing a SIFT-MS breath analysis with the Voice200ultra
We’re thrilled to be leveraging the great relationship that we have with Professor George Hanna, the Head of Department of Surgery and Cancer at Imperial College London, together with our revolutionary SIFT-MS technology, for research that aims to deliver much earlier detection and improved diagnostic outcomes for those suffering from bowel and other gastrointestinal cancers.